Skip to content

RxSight, Inc. RXST Accrued expenses and other liabilities

Accrued expenses and other liabilities at other companies

Under Armour logo
Under ArmourUAA
$143.67M
nCino, Inc. logo
nCino, Inc.NCNO
-$15.29M+3.2%
Perimeter Solutions logo
Perimeter SolutionsPRM
$2.4M-66.9%
ServiceNow logo
ServiceNowNOW
-$439M-53.0%
Mistras Group logo
Mistras GroupMG
-$9.3M-1,440%
Replimune Group logo
Replimune GroupREPL
-$1.91M-136%

Other financials

Income statement

See full
Revenue$30.9M-18.5%
Gross profit$23.5M-17.1%
Operating income-$17.8M-67.0%
Net income-$15.9M-93.9%
EPS (diluted)-$0.38-90.0%

Balance sheet

See full
Cash & equivalents$17.6M-37.2%
Total debt$10.8M-10.1%
Total equity$267.3M-4.3%
Total assets$304.0M-2.9%

Cash flow

See full
Operating cash flow-$10.9M-23.3%
CapEx$759.0K+32.0%
Free cash flow-$11.7M-23.8%

Valuation

See full
Market cap$232.23M-56.8%
Enterprise value$225.49M-55.7%
P/S1.8×-1.8×

Profitability

See full
Gross margin77%+5.1pp
Operating margin-43.4%+128pp
Net margin-36.6%-867pp
FCF margin-16.9%+4.9pp

Returns & leverage

See full
Return on equity-17.1%+12.6pp
Debt / equity0.0×
Current ratio10.2×-2.5×

Where this comes from

Reported directly by RxSight, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about RxSight, Inc.'s accrued expenses and other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RxSight, Inc.'s accrued expenses and other liabilities?
RxSight, Inc. (RXST) reported accrued expenses and other liabilities of -$1.26M in Q1 2026.
How has RxSight, Inc.'s accrued expenses and other liabilities changed year-over-year?
RxSight, Inc.'s accrued expenses and other liabilities increased by 79.6% year-over-year, from -$6.16M to -$1.26M.
What is the long-term trend for RxSight, Inc.'s accrued expenses and other liabilities?
Over 3 years (2021 to 2024), RxSight, Inc.'s accrued expenses and other liabilities has grown at a 16.8% compound annual growth rate (CAGR), from $3.68M to $5.87M.